SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A decrease in the sales to Rs. 3484.89 millions was observed for the quarter ended December 2022. The sales stood at Rs. 3915.85 millions during the similar quarter previous year.The Net Profit of the company registered a slight decline of -20.09% to Rs. 1094.66  millions from Rs. 1369.94 millions.The company reported a degrowth in operating Profit to 1595.77 millions from 1953.02 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 3484.89 3915.85 -11.01 9656.90 9563.74 0.97 13202.22 10097.19 30.75
Other Income 125.10 92.74 34.89 337.97 533.92 -36.70 1877.88 142.37 1219.01
PBIDT 1595.77 1953.02 -18.29 4422.46 4758.11 -7.05 7677.76 4547.59 68.83
Interest 13.79 7.42 85.85 31.02 40.43 -23.27 62.31 91.44 -31.86
PBDT 1581.98 1945.60 -18.69 4391.44 4717.68 -6.92 7615.45 4456.15 70.90
Depreciation 109.14 105.06 3.88 322.18 286.76 12.35 390.97 316.36 23.58
PBT 1472.84 1840.54 -19.98 4069.26 4430.92 -8.16 7224.48 4139.79 74.51
TAX 378.18 470.60 -19.64 1044.87 1094.59 -4.54 1643.49 1053.32 56.03
Deferred Tax 6.66 8.53 -21.92 28.29 33.09 -14.51 67.19 36.17 85.76
PAT 1094.66 1369.94 -20.09 3024.39 3336.33 -9.35 5580.99 3086.47 80.82
Equity 254.57 254.57 0.00 254.57 254.57 0.00 254.57 254.57 0.00
PBIDTM(%) 45.79 49.87 -8.19 45.80 49.75 -7.95 58.16 45.04 29.12

Cohance Lifesciences Share Price

378.15 60.15 (18.92%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×